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Background: In spite of the role of some psychosomatic factors as alexithymia, mood intolerance, and
somatization in both pathogenesis and maintenance of anorexia nervosa (AN), few studies have investigated the
prevalence of psychosomatic syndromes in AN. The aim of this study was to use the Diagnostic Criteria for
Psychosomatic Research (DCPR) to assess psychosomatic syndromes in AN and to evaluate if psychosomatic
syndromes could identify subgroups of AN patients.
Methods: 108 AN inpatients (76 AN restricting subtype, AN-R, and 32 AN binge-purging subtype, AN-BP) were
consecutively recruited and psychosomatic syndromes were diagnosed with the Structured Interview for DCPR.
Participants were asked to complete psychometric tests: Body Shape Questionnaire, Beck Depression Inventory,
Eating Disorder Inventory–2, and Temperament and Character Inventory. Data were submitted to cluster analysis.
Results: Illness denial (63%) and alexithymia (54.6%) resulted to be the most common syndromes in our sample.
Cluster analysis identified three groups: moderate psychosomatic group (49%), somatization group (26%), and
severe psychosomatic group (25%). The first group was mainly represented by AN-R patients reporting often only
illness denial and alexithymia as DCPR syndromes. The second group showed more severe eating and depressive
symptomatology and frequently DCPR syndromes of the somatization cluster. Thanatophobia DCPR syndrome was
also represented in this group. The third group reported longer duration of illness and DCPR syndromes were
highly represented; in particular, all patients were found to show the alexithymia DCPR syndrome.
Conclusions: These results highlight the need of a deep assessment of psychosomatic syndromes in AN.
Psychosomatic syndromes correlated differently with both severity of eating symptomatology and duration of
illness: therefore, DCPR could be effective to achieve tailored treatments.
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It is known in scientific literature that anorexia nervosa
(AN) is a psychosomatic condition [1-3]. Some authors
have recently highlighted the role of several factors like
alexithymia [4], emotion and anger dyscontrol [5], and
somatization [6] in both development and maintenance
of the disorder. It has also been described a psycho-
somatic and somatopsychic vicious circle as underpin-
ning AN symptomatology [7-9].
Moreover, poor interoceptive awareness [10,11] – the
inability of discerning the difference between somatic and
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distribution, and reproduction in any medium- is a hallmark of AN and has been recently supported by
preliminary neuroscientific evidence [12].
In spite of this body of literature, there is a lack of
research systematically investigating the comorbidity of
psychosomatic conditions in AN [13].
The Diagnostic Criteria for Psychosomatic Research
(DCPR) [14] have been proposed to deepen psycho-
somatic aspects. Such criteria suggest a new diagnostic
frame for psychosomatic syndromes characterizing med-
ical and psychiatric conditions to overcome the limits of
the Diagnostic and Statistical Manual-IV (DSM-IV) [15]
as regards somatoform disorders and to formulate a new
approach for the DSM-V [14,16,17]. The DSM-IV chap-
ter on somatoform disorders has been widely criticized
[18]. In particular, its failure to adequately cover the
clinical phenomena of somatisation and models ofentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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Some authors [18,19] have acknowledged that the classifi-
cation of somatoform disorders is not well supported in
scientific literature and that it should be widely modified.
The DSM-IV [15] shows the category of the psychological
factors affecting medical conditions trying to better specify
the psychological aspects but it is used in a very un-
specific way. This may depend on a difficulty of a cat-
egorical psychiatric instrument, as the DSM, to recognize
the subthreshold aspects of psychological distress.
The DCPR system offers an alternative to DSM–IV’s
somatoform disorders but also allows the clinician to
characterize a patient’s mode of perceiving, recognizing,
labelling, and responding to a health status [20]. DCPR
variables may occur in conjunction with any psychiatric
disorder listed in the DSM–IV or with any medical dis-
order [18].
The DCPR have been found to be more suitable than
DSM-IV [15] criteria in describing psychological distress
in a variety of medical settings; moreover, the DPCR repre-
sent an instrument to get through the dichotomy organic/
functional. They also provide a biopsychosocial perspective
in the most common medical conditions [14,21,22].
To date, the DPCR have been used in patients affected
by gastrointestinal, cardiac, dermatological, endocrine,
and neoplastic disorders; in addition, also in patients
affected by somatoform disorder and in consultation-
liaison psychiatry [20,23-29]. In a study conducted on 347
individuals from the general population, alexithymia, type
A behavior, and irritable mood were found as relatively
common DCPR syndromes correlating with worse quality
of life whilst demoralization and persistent somatization
were common in those medically ill and not in the general
population [30].
More recently, the use of the DCPR allowed to indi-
viduate in a large sample of medically ill patients the
association between anxiety and psychosomatic disor-
ders [31] and psychosomatic subtypes of major depres-
sive disorder [32].
Studies of consultation-liaison psychiatry demonstrated
that about 85% of patients showed some DCPR syn-
dromes while 51% was found to have several associated
DCPR syndromes [33].
To the best of our knowledge, in literature there is only
one study, conducted by our group, that applied the four
syndromes of the area “Psychological factors influencing
vulnerability to illness” of DPCR to 101 Eating Disorder
(ED) outpatients [13]. Since it was a preliminary study we
considered only the four syndromes providing a better
specification of the DSM-IV rubric of psychological fac-
tors affecting medical condition, excluding the eight fac-
tors related to somatisation. Our previous paper
investigated all ED diagnoses (AN restricting subtype
[AN-R] and binge-purging subtype [AN-BP], Bulimianervosa, Eating Disorder Not Otherwise Specified inclu-
ding Binge Eating Disorder) using the DCPR. Alexithymia
was the most represented syndrome (52% of the sample),
followed by demoralization (48%), irritable mood (40%),
and type A behavior (27%) with the majority of the sample
reporting at least one DCPR syndrome [13]. Among
diagnostic categories, AN-R patients were found to show
the highest frequency of psychosomatic syndromes
according to the DCPR.
The aforementioned paper by Fassino and Coworkers
[13] provided preliminary data on the utility of assessing
psychosomatic syndromes in ED using the DCPR. It con-
firmed the prevalence of alexithymia, demoralization, and
anger as assessed not only using psychometric measures
[4,34] but also as full syndromes clinically evaluated. The
clinical identification of psychosomatic syndromes confirms
the theoretical psychosomatic model. The latter considers
psychosomatic factors as key-aspects in the pathogenesis of
ED given the central role of lived corporeality and alien-
ation from one own’s body and one own’s emotion [35,36].
To bridge the gap between psychosomatic factors and
ED we conducted this study aiming to: a) replicate and
widen previous data on the prevalence of psychosomatic
syndromes on AN inpatients applying all twelve criteria
on a large sample; b) divide the wide and heterogeneous
AN group according to the DCPR syndromes and clin-
ical variables using a cluster analysis.
Our a priori hypothesis consisted in the identification
of clusters with different prevalence of DCPR syndromes
and clinical and psychosocial features.
Methods
The study population consisted of 108 AN inpatients con-
secutively hospitalized at the ED Centre of the University
of Turin, Italy, over a period of two years. Hospitalization
occurred during patients’ emergency phase; according to
international guidelines [37], hospitalization was needed
on the bases of psychiatric and behavioral factors, in-
cluding a rapid or persistent decline in oral intake or
co-occurring psychiatric problems leading to medical
instability, abnormalities in vital signs and laboratory tests.
Moreover, patients’ degree of denial and resistance was
high. Patients were approached by a researcher not ac-
tively participating in the clinical work.
Therefore, hospitalization was required to treat acute
episodes and to provide tailored aftercare programs,
including partial hospitalization. The duration of the
intensive inpatient treatment was individualized and -
differently from rehabilitation programs - hospitalization
did not aim to achieve full weight restoration. All indivi-
duals were diagnosed with an ED, distributed as follows:
76 with AN-R and 32 with AN-BP. Exclusion criteria
were: (1) medical comorbidity preceding the AN onset
(e.g., epilepsy or diabetes); (2) male gender; (3) actual
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(1) full-criteria diagnosis of AN [15]; (2) female gender.
All participants provided written informed consent
according to the Ethical Committee of the Department
of Neuroscience of the University of Turin.
The initial sample included 120 individuals, but 2
patients refused to be included in this study, 6 patients
were male, 3 showed severe medical comorbidity and 1
was excluded because of current psychosis (paranoid brief
episode in a patient affected by severe borderline perso-
nality disorder), so the sample consisted of 108 participants.
All the patients were assessed by psychiatrists with
the Structured Clinical Interview for DSM-IV Axis-I
Disorders (SCID-I) [38].
All participants were asked to complete psychometric
tests: Body Shape Questionnaire (BSQ) to evaluate body
image, Beck Depression Inventory (BDI) for a dimensional
assessment of depressive symptoms, Eating Disorder
Inventory–2 (EDI-2) to assess eating symptomatology,
and Temperament and Character Inventory (TCI) to di-
mensionally assess personality. Interviews and tests have
been collected during the first week of hospitalization.
Psychosomatic syndromes were diagnosed with the
Structured Interview for DCPR [39].
The body shape questionnaire
The BSQ [40] is a 34-item self-report questionnaire that
assesses body image and concerns about body shape.
The participants have to respond to items regarding how
they have felt about their body shape in the last few
weeks choosing among 6 degrees of severity.
The BSQ showed good internal consistency (Cronbach
alpha 0.97) [41] and test-retest reliability (0.88) [42].
The beck depression inventory
The BDI [43] is a 13-item self-report questionnaire used
to evaluate the severity of depressive symptoms.
The BDI demonstrated high internal consistency, with
alpha coefficients of 0.86 and 0.81 for psychiatric and
non-psychiatric populations, respectively [44]; Beck and
Coworkers [43] did not recommend conventional test-
retest reliability, however Groth-Marnat [45] reported
that test retest reliabilities ranged from 0.48 to 0.86.
The eating disorder inventory – 2
The EDI-2 [46] is a self-report inventory that measures
disordered eating attitudes and behaviors and personality
traits common to individuals diagnosed with ED.
The test-retest reliabilities on patients with eating dis-
orders were between 0.81 and 0.89 and on patients with
other diagnoses, revealed similar correlations, ranging
from a minimum of 0.75 to a maximum of 0.94. No dif-
ference in test–retest reliability was found between the
two groups of patients with eating disorders and otherdiagnoses. It was found a high level of internal consistency
of these four scales, indicated by Cronbach’s alpha values
between 0.82 and 0.93 [47].
The temperament and character inventory
The TCI [48] is a 240-item self-administered questionnaire
divided into 7 dimensions. Four of these dimensions assess
temperament (Novelty Seeking [NS], Harm Avoidance
[HA], Reward Dependence [RD] and Persistence [P]). The
other 3 dimensions of the TCI assess character, defined
as the overall personality traits acquired through experi-
ence (Self-directedness [SD], Cooperativeness [C], and
Self-transcendence [ST]).
Cronbach alpha values for the TCI scales ranged from
0.60 to 0.85 for the temperament scales and from 0.82
to 0.87 for the character scales. Test-retest correlations
ranged from 0.52 to 0.72 for temperament and from
0.52 to 0.71 for character dimentions [49].
The diagnostic criteria for psychosomatic research
The DCPR are a diagnostic and conceptual framework
consisting of both clinical syndromes and personality
concepts used to translate psychosocial variables derived
from Psychosomatics into operational instruments able
to identify individual patients in psychosomatic and
behavioural medicine [33]. A structured interview was
developed to assess the presence of the 12 syndromes:
health anxiety, irritable mood, demoralization, illness
denial, alexithymia, type A behavior, thanatophobia,
disease phobia, functional somatic symptoms secondary
to a psychiatric disorder, persistent somatization, conver-
sion syndrome, and anniversary reaction [39,50]. The
DCPR syndromes can be identified using an interview
composed of 58 questions with yes or no answers [50].
Their overlap rates with DSM-IV diagnoses showed that
the DCPR syndromes were able to identify psychological
dimensions that do not meet DSM-IV criteria [39]. The
DCPR were developed also to provide clinicians with oper-
ational criteria for psychosomatic syndromes to overcome
the limitations shown by the most often diagnosed disor-
ders in medical settings [39].
The Structured Interview for DCPR showed excellent
interrater reliability with kappa values ranging from 0.69
to 0.97 [51]. It showed also good correlations with di-
mensional instruments for the assessment of psycho-
social distress such as the Toronto Alexithymia Scale
[52,53], the Psychosocial Index [54], and the General
Health Questionnaire [55].
Statistical analysis
For statistical analysis, we used the Statistical Package for
Social Sciences (SPSS 13.0 Application Guide. Chicago:
SPSS, Inc., 2004). Descriptive statistics were computed.
Categorical data were compared using the Chi-square test,
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dependent samples.
Subsequently, a two-step cluster analysis was performed
to gather cases into separate groups of patients with simi-
lar characteristics. The variables we considered to group
participants were: DCPR syndromes, AN subtypes, Body
Mass Index (BMI), duration of illness and age.
The two-step cluster method is a scalable cluster ana-
lysis algorithm designed to manage heterogeneous data
sets. It can handle both continuous and categorical vari-
ables. The two steps are: 1) pre-cluster the cases into
many small sub-clusters; and 2) cluster the sub-clusters
resulting from pre-cluster step into the desired number
of clusters. The log-likelihood distance measure was
used, with participants assigned to the cluster leading to
the largest likelihood.
A defined number of clusters was not defined a
priori. Solution was found with the Bayesian Informa-
tion Criterion.
Then we compared the groups: categorical data were
compared using the Chi-square test, and continuous
data were analysed using ANOVA and post hoc t-test
for independent samples.
A level of significance of alpha < 0.05 was considered.
Results
Sociodemographic and clinical features of the sample
Table 1 shows sociodemographic and clinical characteris-
tics of the sample. AN-BP individuals were characterized
by older age and longer duration of illness.
All groups did not differ regarding sociodemographic
variables.
Psychiatric assessment
AN-BP patients reported higher scores on the TCI as
regards NS and ST dimensions, on the EDI-2 scores in
bulimia, asceticism, impulsiveness, and social insecurity
scales, and on the BDI. BSQ scores were very similar
between AN-R and AN-BP (see Table 1).
Diagnostic criteria for psychosomatic research
The 6.4% of AN patients (6.6% AN-R; 6.1% AN-BP)
showed no psychosomatic syndromes, 46.8% from 1 to 3
psychosomatic syndromes (51.3% AN-R; 36.4% AN-BP),
and 46.8% of participants more than 3 psychosomatic
syndromes (42.1% AN-R; 57.5% AN-BP). No diffe-
rences were found between AN-R and AN-BP sub-
groups (Chi-Square 2.286, p < 0.319).
Illness denial (63%) and alexithymia (54.6%) were the
most common DCPR syndromes; in fact, they were
found in more than 50% of the whole AN sample. See
Table 2 for details of DCPR syndromes.
The two-step cluster analysis individuated three mutu-
ally exclusive groups.1. The first group was the largest (N = 53) and it was
composed by a larger number of AN-R individuals
than the second group. In this group the DCPR
syndromes were generally significantly less represented
than in the other two groups. The most frequent
syndromes were denial of illness and alexithymia
(see Table 3). This cluster was labelled as moderate
psychosomatic group.
As regards clinical and assessment comparisons among
groups see Table 4.
2. The second cluster (N = 28) showed a higher BMI. In
this group AN-BP patients were more frequently
found than in the other two groups. DCPR
syndromes were common in this group: in particular,
it was characterized by higher levels of
thanatophobia, conversion symptoms and
anniversary reaction; they were significantly higher
than both other groups. This cluster was labelled as
somatization group (see Table 3).
As regards clinical and assessment comparisons among
groups see Table 4.
3. In the third group (N = 27) AN-R patients were more
represented when compared to the second group.
DCPR syndromes in this group were extremely
frequent: more than 85% of the patients showed
health anxiety, illness denial, irritability, and
demoralization. All patients in this group reported
the alexithymia syndrome. This group was labelled as
severe psychosomatic group (see Table 3).
As regards clinical and assessment comparisons
among groups, the third group showed a longer duration
of illness than group 1 (see Table 4).
Although there was no statistical significance, the first
group showed shorter hospitalizations than both other
groups (days of hospitalization: 29.3 ± 15.5 vs 32.8 ± 28.8 vs
32.6 ± 27.9; df = 2, F 0.291) with a shorter range between
maximum and minimum duration (days of hospitalization:
3–90 vs 9–128 vs 12–160).
Discussion
DCPR and AN
This study aimed to assess on a sample of AN inpatients
the comorbidity with psychosomatic syndromes using
the DCPR [50].
The great majority of the sample reported a psycho-
somatic syndrome (93.6%) and almost half of the sample
(46.8%) showed more than three comorbid psychosomatic
syndromes, confirming the relevance of psychosomatic
factors in ED [4,6], even higher than in medically ill
Table 1 Sociodemographic and clinical features of the sample
AN-R AN-BP Total sample Chi-square/t p
(N = 76) (N = 32) (N = 108)
Married (%) 12 14 13 0.041 0.839
Living alone (%) 6 10 9 0.211 0.644
Occupation (%) 22 28 24 0.240 0.624
Age (mean ± SD) 26.1 ± 9.1 30.7 ± 8.9 27.4 ± 9.2 −2.477 0.016
Years of education (mean ± SD) 12.9 ± 2.6 13.4 ± 3.1 13.1 ± 2.6 −0.479 0.637
Body Mass Index (mean ± SD) 14.8 ± 2.4 15.2 ± 3.3 14.9 ± 2.7 −0.865 0.392
Number of previous outpatient treatments (mean ± SD) 0.6 ± 0.8 0.7 ± 0.9 0.6 ± 0.9 −0.364 0.718
Duration of illness (years, mean ± SD) 7.8 ± 8.2 12.4 ± 8.4 9.1 ± 8.5 −2.652 0.009
Age of onset (years, mean ± SD) 18.3 ± 6.1 18.2 ± 5.2 18.3 ± 5.8 −0.072 0.942
Number of hospitalizations in the previous year (mean ± SD) 1.1 ± 1.7 1.92 ± 3.4 1.4 ± 2.4 −1.046 0.302
TCI
Novelty seeking 16.3 ± 5.7 19.4 ± 6.1 −2.401 0.018
Harm avoidance 23.4 ± 11.3 21.5 ± 8.0 0.849 0.398
Reward dependence 14. ± 3.9 12.5 ± 4.5 1.762 0.081
Persistence 6.4 ± 9.6 5.2 ± 2.7 0.663 0.509
Self-directedness 23.8 ± 9.7 20.1 ± 7.5 1.840 0.069
Cooperativeness 31.0 ± 7.6 29.4 ± 7.3 0.999 0.320
Self-trascendence 12.6 ± 6.5 15.8 ± 5.9 2.346 0.021
EDI-2
Drive for thinness 10.9 ± 7.6 10.2 ± 6.9 0.385 0.701
Bulimia 2.5 ± 3.7 6.1 ± 6.3 −3.516 0.001
Body dissatisfaction 12.2 ± 6.7 13.7 ± 7.7 −0.910 0.365
Ineffectiveness 9.6 ± 8.0 11.9 ± 8.2 −1.261 0.210
Perfectionism 5.3 ± 4.3 6.6 ± 4.6 −1.248 0.215
Interpersonal distrust 6.7 ± 5.4 8.1 ± 5.7 −1.135 0.259
Interoceptive awareness 10.4 ± 7.9 12.5 ± 9.1 −1.130 0.261
Maturity fears 7.4 ± 5.3 8.4 ± 6.3 −0.747 0.457
Asceticism 6.9 ± 4.7 9.7 ± 6.4 −2.332 0.022
Impulse regulation 5.9 ± 6.1 9.5 ± 7.4 −2.504 0.014
Social insecurity 7.5 ± 5.1 10.3 ± 5.6 −2.359 0.020
BSQ 103.1 ± 42.1 103.2 ± 48.3 −0.006 0.995
BDI 14.8 ± 7.5 17.0 ± 8.0 −1.259 0.211
Legend:
AN-R: Anorexia Nervosa Restricting type.
AN-BP: Anorexia Nervosa Binge-Purging type.
TCI: Temperament and Character Inventory.
EDI-2: Eating Disorder Inventory-2.
BSQ: Body Dissatisfaction Questionnaire.
BDI: Beck Depression Inventory.
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dromes can be due both to the exaggerated focusing on
the body in AN [56,57] and to all those psychic alterations
leading to somatic ones and vice versa. This spiral mech-
anism could play a key-role in both maintaining the dis-
order [8,9] and triggering the onset of psychosomaticsyndromes, particularly in severe and acute patients like
those of this study.
Analising each syndrome, it should be noted that two
psychosomatic syndromes (illness denial and alexithymia)
were diagnosed in more than 50% of AN patients and that
they were both significantly represented in all clusters of
Table 2 Psychosomatic diagnoses: percentages of affected patients for each diagnosis
AN-R AN-BP Total sample Chi-square p
% (N) % (N) % (N)
Illness denial 61.8% (47) 65.6% (21) 63% (68) 0.138 0.710
Alexithymia 52.6% (40) 59.4% (19) 54.6% (59) 0.413 0.520
Demoralization 43.4% (33) 62.5% (20) 49.1% (53) 3.280 0.071
Functional symptoms 38.2% (29) 50% (16) 41.7% (45) 1.299 0.254
Type A behaviour 35.5% (27) 43.8% (14) 38% (41) 0.647 0.421
Irritable mood 30.3% (23) 50% (16) 36.1 (39) 3.802 0.051
Conversion symptom 21.1% (16) 28.1% (9) 23.1% (25) 0.633 0.426
Health anxiety 25% (19) 18.8% (6) 23.1% (25) 0.494 0.482
Anniversary reaction 7.9% (6) 18.8% (6) 11.1% (12) 2.687 0.101
Persistent somatization 9.2% (7) 12.5% (4) 10.2% (11) 0.266 0.606
Disease phobia 5.3% (4) 12.5% (4) 7.4% (8) 1.719 0.190
Thanatophobia 6.6% (5) 6.3% (2) 6.5% (7) 0.004 0.949
Abbate-Daga et al. BMC Psychiatry 2013, 13:14 Page 6 of 11
http://www.biomedcentral.com/1471-244X/13/14this study. It is noteworthy that both syndromes are well-
known factors involved in both maintaining the disorder
and in resistance to treatment. These data are in line with
literature since these two syndromes have been suggested
as possible psychosomatic key-elements for some diagnos-
tic or psychopathological factors [58,59].
Illness denial – the most frequent syndrome – represents
an important factor to explain patients’ obstinate treatment
refusal [60], high rates of drop-out [61], and their well-
known difficulty to maintain a trusting relationship with
their psychotherapist [57,60].Table 3 Psychosomatic diagnostic categories within each clus





AN-BP subtype 25% (8) 53%
AN-R subtype 57% (44) 15%
Health anxiety 0% (0) 7%
Disease phobia 0% (0) 14%
Thanatophobia 2% (1) 21%
Illness denial 52% (27) 54%
Functional symptoms 15% (8) 64%
Persistent somatization 6% (3) 21%
Conversion symptom 12% (6) 60%
Anniversary reaction 0% (0) 39%
Type A behaviour 19% (10) 57%
Irritable mood 2% (1) 54%
Demoralization 19% (10) 61%
Alexithymia 38% (20) 39%
Legend:
AN-R: Anorexia Nervosa Restricting type.
AN-BP: Anorexia Nervosa Binge-Purging type.Alexithymia describes ED patients’ emotive inability and
it is considered more trait rather than state-dependent in
ED pathogenesis [62]. Eating symptomatology has been
suggested to represent a strategy to avoid emotions [63]
and the impairment in recognizing and expressing them
could generate body symptoms as “concretized meta-
phors” describing a psychic equivalence between physical
and psychic reality with concretized emotions as a result
[35]. As Skårderud states “Concretized metaphors refer to
instances where the metaphors are not experienced as
indirect expressions showing something thus mediated,ter






(12) 27% (20) 15.58 0.001
(2) 85% (23) 77.59 0.001
(4) 15% (4) 8.18 0.017
(6) 0% (0) 13.85 0.002
(15) 93% (15) 13.88 0.001
(18) 70% (19) 29.74 0.001
(6) 7% (2) 5.16 0.076
(17) 7% (2) 29.716 0.001
(11) 0% (0) 34.59 0.001
(16) 56% (15) 15.60 0.001
(15) 85% (23) 57.99 0.001
(17) 96% (26) 44.12 0.001
(11) 100% (27) 30.51 0.001







F F Sign p Group 1 vs
Group 2
p Group 2 vs
Group 3
p Group 1 vs
Group 3
Group 1 (N = 53)
mean ± SD
Group 2 (N = 28)
mean ± SD
Group 3 (N = 27)
mean ± SD
BMI 14.6 ± 1.9 16.1 ± 3.3 14.1 ± 2.7 4.88 0.009 0.037 0.012 1.000
EDI-2
Bulimia 2.8 ± 4.7 6.3 ± 6.1 2.5 ± 2.4 5.31 0.007 0.010 0.021 1.000
Body
dissatisfaction 11.12 ± 7 16.8 ± 6.7 12 ± 5.6 6.0 0.004 0.003 0.046 1.000
Ineffectiveness 7.5 ± 7.1 15.9 ± 8.5 11.0 ± 6.9 10.11 0.001 0.001 0.089 0.189
Perfectionism 4.6 ± 3.6 7.4 ± 4.7 6.4 ± 5.1 3.84 0.025 0.030 1.000 0.296
Interoceptive
awareness 8.7 ± 7.3 17.8 ± 8.1 10 ± 6.8 12.27 0.001 0.001 0.002 1.000
Asceticism 5.9 ± 4.1 11.2 ± 6.4 8.4 ± 5.1 8.85 0.001 0.001 0.201 0.152
Impulsiveness 4.2 ± 5.1 13.8 ± 7 6.6 ± 4 24.5 0.001 0.001 0.001 0.251
Social
insecurity 6.5 ± 4.9 12 ± 5.7 8.6 ± 4.2 9.5 0.001 0.001 0.078 0.277
BSQ 89 ± 34.2 140.6 ± 40.4 93.2 ± 42.8 8.33 0.001 0.001 0.006 1.000
TCI
Self-
Directedness 24.8 ± 9.9 16.6 ± 5.2 24.2 ± 8.2 8.19 0.001 0.001 0.009 1.000
BDI 12.3 ± 6.9 21.9 ± 6.6 14.7 ± 5.5 16.71 0.001 0.001 0.002 0.569
Duration of
illness (years) 7.9 ± 8.8 7.8 ± 6.1 12.6 ± 9.1 3.25 0.043 1.000 0.108 0.049
Legend:
BMI: Body Mass Index.
EDI-2: Eating Disorder Inventory-2.
BSQ: Body Shape Questionnaire.
TCI: Temperament and Character Inventory.
BDI: Beck Depression Inventory.
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of a concrete reality. There is an immediate equivalence
between bodily and emotional experience” [35].
Comparing descriptive data of the whole sample to
those of our previous study on ED outpatients [13], the
current sample differs as regards the higher frequency of
type A behavior. This different result can be due to dif-
ferent sampling criteria: in fact, we previously included
outpatients and individuals affected also by Binge Eating
Disorder. It is indeed largely known that AN patients –
compared to other ED individuals - behave in a more
controlled and perfectionistic way [64]. Moreover, the
present sample included AN inpatients in an emergency
phase: it could also be hypothesized that type A behavior
diagnostic category is less stable in time and more state-
dependent than other categories.
The rates of psychosomatic syndromes obtained by
using DCPR (see Table 2) did not differ significantly
between AN subtypes. In AN-BP patients it could be
also observed a higher prevalence of demoralization,
even if not significant. These findings are in line withprevious data in literature reporting a more frequent
comorbid depressive symptomatology and anger dyscon-
trol in this subtype of AN [65,66].
DCPR and clusters
The second aim of this study consisted in grouping the
sample into more specific clusters to better characterize
the link between psychosomatic syndromes and DCPR.
Compared with limited DSM-IV ED diagnoses, clusters
allow a more clearly differentiated characterization of
patients subgroups on a broad range of features. Previ-
ous researches considering clusters had a clinical utility
[67,68]. In our study, a cluster analysis allowed to iden-
tify specific association patterns between AN and psy-
chosomatic syndromes. It is well-known that ED can
also be subdivided according to personality features in
different ways [69-71]. It is possible that different per-
sonality styles associated to ED can correspond to differ-
ent psychosomatic clusters. In fact, AN patients who are
mainly characterized by a perfectionistic and inhibited
style are more represented by cluster 1 whilst AN-BP,
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in cluster 2. Therefore, the use of psychosomatic clusters
reinforces the idea of different personality styles and psy-
chopathological variability in AN. From a clinical stand-
point, to identify patients on the bases of their problems
of somatization versus personality and alexithymia could
mean to use different treatments, as debated below.
The TCI provided less data than expected as regards clus-
ters mostly about temperament dimensions. However, it is
of interest that the somatization group showed lower Self-
directedness (SD) than other groups. Since SD quantifies
the extent to which an individual is responsible, reliable,
resourceful, goal-oriented, and self-confident it is note-
worthy that the group showing a more immature character
expresses distress through corporeality. Maybe this group
has less resources to verbalize problems; therefore, therapy
should address such an impairment: psychotherapy needs
to consider the possible hindrance represented by the
poorer expressive tools of this subgroup.
The cluster analysis individuated three clusters: mo-
derate psychosomatic, somatization, and severe psycho-
somatic group.
The first group represented about a half of the sample
and the psychosomatic syndromes were relatively
scarcely represented (6 syndromes out of 12 were lower
than 10%; see Table 4). The most represented syndromes
of the first group were illness denial (52%) and alexithy-
mia (38%) since these syndromes were highly repre-
sented also in other groups it could be raised the
hypothesis that such features can be shared by AN indi-
viduals. It is noteworthy that this group seemed to be
mostly represented by AN-R individuals (85%), with less
severe eating symptomatology than group 2 and with
shorter duration of illness than group 3. Given the
cross-sectional design of this study it cannot be clarified
if less psychosomatic syndromes are causes or conse-
quences of severity of illness or duration of illness. How-
ever, it is clear that a smaller number of psychosomatic
syndromes mean a better clinical condition at the mo-
ment of assessment. Still, even though the datum is not
statistically significant, this group required shorter hos-
pitalizations than the other groups.
The second group (somatization group) assembled
patients with severe eating psychopathology, mostly AN-
BP, well-known feature influencing negatively prognosis
[72]. In spite of higher BMI, this finding is not in contra-
diction with a more severe psychopathology; in fact,
BMI is representative of the somatic – rather than psy-
chiatric – clinical severity [73]. Patients seemed to show
higher character immaturity than the other groups: also
this element indicates higher severity [66].
Moreover, in this group was found high depressive
symptomatology, generally associated to the severity of
eating psychopathology [66]. The majority of patients inthis group reported psychosomatic problems (6 psycho-
somatic syndromes have been found in more than 50%
of the sample; see Table 3). In particular, the clinical
severity of this cluster was associated with thanatophobia
(found almost exclusively in this group), somatization area
(persistent somatization, conversion symptom and anni-
versary reaction) and type A behavior. These syndromes
could be indeed considered as severity indexes of ED.
Thanatophobia can be associated to both a more
severe psychiatric comorbidity and the awareness of
higher risks of death due to hypokalemia, condition
linked to purging behaviors [73].
Somatization has not been well deepened in the ED
population, even if some studies have recently described
the relationship between functional symptomatology and
ED, in particular the gastroenteric functional symptoms
[74,75]. From a clinical standpoint, it could be difficult
to diagnose as organic or functional a gastrointestinal
disease referred by ED patients; anyway it is well-known
that ED patients’ body sensations – often inappropriately
experienced – can influence the disease and its course
[11]. Moreover, in this subgroup were also clearly repre-
sented some conversion symptoms, only sporadically
discussed in AN patients [76,77]. Hence, it should be con-
sidered that for some AN patients – as in this cluster -
body language can be a further sign of their clinical
severity, requiring a clinical approach specifically tailored
to these conversion aspects, often a neglected issue in
AN treatment.
Still, the high frequency of type A behavior (54%) in
this group could be strictly related to both need of control
and perfectionism, core elements and severity indexes of
AN [64].
The third group was extremely characterized by psy-
chosomatic aspects (6 syndromes have been found in
more than 70% of the sample; see Table 4). In particular,
in this group have been found high percentages of health
anxiety (85%) - in contrast with the other groups - and
high percentages of psychosomatic syndromes of those
psychological factors influencing illness vulnerability.
Moreover, AN individuals of this group showed a du-
ration of illness significantly higher than the first group.
Anxiety traits and symptoms are widely known in a
subgroup of AN patients and they can influence nega-
tively their prognosis [78]. It is noteworthy that in this
subgroup the DCPR health anxiety syndrome is asso-
ciated to a longer duration of the illness. Health anxiety
could be indeed explained by a heavier burden of disease
after many years of AN.
Finally, almost all patients in this group deny illness
(93%), hardly recognize and express their feelings (100%),
and are frequently irritated (85%) or demoralized (96%).
From a clinical standpoint, it should be noted that feelings
of loss of hope and anger lower patients’ motivation, key
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researches should investigate if early demoralization can
predict early drop-out, worse long-term outcome and
consecutively entail a longer duration of ED or if it is the
long duration of illness to make patients more alexithy-
mic, irritable, and demoralized. It should be noted that
this subgroup highlights that long-standing patients show
more psychosomatic problems and that the latter can fur-
ther strengthen the eating vicious circle [8]. Probably, AN
treatments should mainly address the “give–up syndrome"
that can arise considering patients' low motivation and
previously failed treatments [8]. This intervention could
be preliminary to the specific ED treatment and it could
help not to thwart clinical efforts.
Conclusions
This study shows several limitations. First, it is cross-
sectional and so it is not possible to individuate to what
extent DPCR in AN is state-independent or stable in
time. Second, the presence of organic symptomatology
in AN individuals could be a bias overestimating or
underestimating some syndromes as persistent func-
tional symptoms. Third, the considered sample is large
but including only AN inpatients and so the results can-
not be generalized to less severe patients. Still, more
AN-R than AN-BP patients were included and it would
be interesting to replicate DCPR evaluation also in other
ED Centres and with a comparison group. From a statis-
tical standpoint, corrective measures for the post-hoc
test (e.g., the Bonferroni correction) were not used. Fi-
nally, a limitation of this study is the lack of a control
group. However, comparing our data to the ones in lit-
erature on the general population [30], it should be
noted that ED patients are more often affected by psy-
chosomatic syndromes. When compared to depressed
patients [81] the percentages of psychosomatic syn-
dromes did not differ but illness denial and alexithymia
were less represented in depressed patients that in AN,
raising the hypothesis of different psychosomatic pat-
terns among psychiatric diagnoses.
Considering the aforementioned limitations, this work
highlights the role of psychosomatic factors – neglected
topic in the last decades of ED research [9,13] - in AN.
The study provides support to the clinical utilization of
DCPR to assess patients with a more complex approach.
Still, the identification of clusters could have relevant
therapeutic implications. It is well-known in literature that
those patients who are highly alexithymic receive overall
more treatments – and significantly more antidepressants
rather than psychotherapy - than those without these traits
[82]. The cluster showing higher alexithymia represents
instead a caveat as regards undergoing psychotherapy.
Moreover, somatization issues in ED – as reported in
cluster 2 - represent a quite new research field as de-monstrated by the current dearth of studies; lived corpor-
eality [36] should be addressed more in therapy with
patients of this group. Given their common comorbidity
with borderline personality traits – usually highlighting
themes of somatic preoccupation and somatization dis-
order [83] -, AN-BP patients often report such features,
which should be specifically considered in therapy.
The study reports indeed that the majority of AN
patients shows psychosomatic elements and also that such
elements are relevant for both patients’ assessment and
treatments. This can support the introduction of a more
complex clinical practice able to provide tailored treat-
ments [9] in conjunction with the categorical diagnostic
system reporting patients - eventually deceptively - as
similar [31]. In particular, alexithymia and illness denial
resulted to be common syndromes in AN individuals:
these syndromes well describe some core factors of ED
patients’ resistance to treatments [59,84] and drop-out
[61].
Psychosomatic syndromes allow to identify subgroups
of patients with different features; particularly, we found
that 25% of the AN sample reported relevant psycho-
somatic problems probably associated to longer duration
of illness. Clinicians should carefully consider these ele-
ments to provide more effective treatments and to achieve
more compliance to therapy. Further longitudinal studies
are warranted to shed light on psychosomatic syndromes
and their utilization in clinical practice.Competing interests
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